Courtney E. Maus, Ph.D.
Affiliations: | 2005 | Emory University, Atlanta, GA |
Area:
Microbiology Biology, Genetics, Public HealthGoogle:
"Courtney Maus"Cross-listing: Microtree
Parents
Sign in to add mentorThomas M. Shinnick | grad student | 2005 | Emory (Microtree) | |
(Capreomycin resistance in Mycobacterium tuberculosis: Identification the molecular mechanism of resistance and characterization of cross-resistance to ribosome -inhibiting drugs.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shah M, Paradis S, Betz J, et al. (2019) Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Murray P, Cooper C, Maus C. (2019) Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays. Journal of Clinical Microbiology. 57 |
Johansen SK, Maus CE, Plikaytis BB, et al. (2006) Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs. Molecular Cell. 23: 173-82 |
Maus CE, Plikaytis BB, Shinnick TM. (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 49: 3192-7 |
Maus CE, Plikaytis BB, Shinnick TM. (2005) Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 49: 571-7 |